The Motley Fool··Prosper Junior BakinyHantavirus Biotech Boom Masks Fundamental Risks; Investors Should Proceed With Caution
Hantavirus biotech rally sparked by cruise ship outbreak, but analysts warn fundamental transmission and vaccine market constraints limit opportunity. Success prediction remains impossible.
MRKPFESNYMRNABNTX+2investment strategyvaccine development